tiprankstipranks
Relmada Therapeutics Inc (RLMD)
NASDAQ:RLMD
US Market
Want to see RLMD full AI Analyst Report?

Relmada Therapeutics (RLMD) Technical Analysis

439 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Relmada Therapeutics Inc’s (RLMD) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Relmada Therapeutics Inc is a Buy.
Relmada Therapeutics Inc’s (RLMD) 20-Day exponential moving average is 7.08, while Relmada Therapeutics Inc’s (RLMD) share price is $7.48, making it a Sell.
Relmada Therapeutics Inc’s (RLMD) 50-Day exponential moving average is 6.82, while Relmada Therapeutics Inc’s (RLMD) share price is $7.48, making it a Sell.

Relmada Therapeutics (RLMD) Pivot Points

Jun 03, 2026, 11:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.44
6.63
6.74
6.93
7.04
7.23
7.34
Fibonacci
6.63
6.74
6.82
6.93
7.04
7.12
7.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relmada Therapeutics (RLMD) Moving Averages

Jun 03, 2026, 11:50 PM
Period
Simple
Exponential
MA5
7.00Sell
6.86Sell
MA10
7.06Sell
6.99Sell
MA20
7.18Sell
7.08Sell
MA50
7.09Sell
6.82Sell
MA100
5.81Buy
6.01Buy
MA200
4.27Buy
4.41Buy
Relmada Therapeutics Inc’s (RLMD) 10-Day exponential moving average is 6.99, while Relmada Therapeutics Inc’s (RLMD) share price is $7.48, making it a Sell.
Relmada Therapeutics Inc’s (RLMD) 100-Day exponential moving average is 6.01, while Relmada Therapeutics Inc’s (RLMD) share price is $7.48, making it a Buy.
Relmada Therapeutics Inc’s (RLMD) stock price is $7.48 and Relmada Therapeutics Inc’s (RLMD) 50-day simple moving average is 7.09, creating a Sell signal.
Relmada Therapeutics Inc’s (RLMD) stock price is $7.48 and Relmada Therapeutics Inc’s (RLMD) 100-day simple moving average is 5.81, creating a Buy signal.
Relmada Therapeutics Inc’s (RLMD) stock price is $7.48 and Relmada Therapeutics Inc’s (RLMD) 200-day simple moving average is 4.27, creating a Buy signal.

Relmada Therapeutics (RLMD) Technical Indicators

Jun 03, 2026, 11:50 PM
Name
Value
Implied Action
RSI (14)
38.41
Neutral
STOCH (9,6)
48.59
Neutral
STOCHRSI (14)
44.82
Neutral
MACD (12,26)
-0.06
Buy
ADX (14)
20.22
Neutral
Williams %R
-80.58
Buy
CCI (14)
-203.10
Buy
ATR (14)
0.44
-
Ultimate Oscillator
43.20
Neutral
ROC
-13.83
Sell
Relmada Therapeutics Inc’s (RLMD) Relative Strength Index (RSI) is 38.41, creating a Neutral signal.
Relmada Therapeutics Inc’s (RLMD) Trend Strength Indicator (ADX) is 20.22, creating a Neutral signal.
Relmada Therapeutics Inc’s (RLMD) Commodity Channel Index (CCI) is -203.10, creating a Buy signal.
Relmada Therapeutics Inc’s (RLMD) Price Rate of Change (ROC) is -13.83, creating a Sell signal.

FAQ

Is RLMD a Buy, Hold, or Sell?
Based on RLMD’s technical indicators, RLMD is a Sell.
    What is RLMD’s RSI (14)?
    RLMD’s RSI (14) is 38.41, which suggests RLMD is a Neutral.
      What is RLMD’s MACD?
      RLMD’s MACD is -0.06, which suggests RLMD is a Buy.
        What is RLMD’s 5-day moving average?
        RLMD’s 5-day moving average is 7.00, which suggests RLMD is a Sell.
          What is RLMD’s 20-day moving average?
          RLMD 20-day moving average is 7.18, which suggests RLMD is a Sell.
            What is RLMD’s 50-day moving average?
            RLMD’s 50-day moving average is 7.09, which suggests RLMD is a Sell.
              What is RLMD’s 200-day moving average?
              RLMD’s 200-day moving average is 4.27, which suggests RLMD is a Buy.
                What is RLMD’s Williams % R (14)?
                RLMD’s Williams % R (14) is -80.58, which suggests RLMD is a Buy.
                  What is RLMD’s CCI (14)?
                  RLMD’s CCI (14) is -203.10, which suggests RLMD is a Buy.